Literature DB >> 7497147

Is psychological wellbeing impaired in long-term survivors of breast cancer?

R Ellman1, B A Thomas.   

Abstract

OBJECTIVE: To measure anxiety and depression in long term survivors of breast cancer.
DESIGN: Case-control study.
SETTING: Follow up of the trial of early detection of breast cancer in the South West Surrey Health District.
SUBJECTS: 331 patients with breast cancer aged 50-78, attending mammographic follow up, who had been invited to screening before diagnosis, and 584 controls who had attended the same clinic but did not have breast cancer. The sample included 290 pairs matched by screening attendance pattern and year of birth. MAIN OUTCOME MEASURE: Anxiety and depression scores on the Hospital Anxiety and Depression Scale.
RESULTS: Significantly fewer symptoms of anxiety and depression were reported by patients with cancer than by controls and significantly fewer had high scores suggesting the presence of psychological morbidity meriting treatment. Among the patients with cancer anxiety was more common at the first annual follow up than at later visits. Symptom scores were not significantly related to the manner of detection or to the type of initial treatment. Potentially confounding social and personal factors did not account for the differences between patients with cancer and controls.
CONCLUSION: The prevalence of anxiety and depression is not increased in long term survivors of breast cancer who are apparently free from disease and is not substantially affected by the manner in which a cancer is detected or by the treatment given. In the light of these findings it is difficult to justify large "quality adjustments" to the estimates of recurrence-free years of life saved by screening. Those who counsel patients with breast cancer should be aware that although the initial distress can be severe, meriting psychological treatment, patients do recover their normal ability to enjoy life.

Entities:  

Mesh:

Year:  1995        PMID: 7497147     DOI: 10.1177/096914139500200103

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  6 in total

1.  Factors affecting health-related quality of life in women with recurrent breast cancer in Korea.

Authors:  Myung Kyung Lee; Byung Ho Son; Sook Yeon Hwang; Wonshik Han; Jung-Hyun Yang; Seeyoun Lee; Young Ho Yun
Journal:  Qual Life Res       Date:  2007-02-06       Impact factor: 4.147

2.  The value of the Hospital Anxiety and Depression Scale (HADS) for comparing women with early onset breast cancer with population-based reference women.

Authors:  R H Osborne; G R Elsworth; M A G Sprangers; F J Oort; J L Hopper
Journal:  Qual Life Res       Date:  2004-02       Impact factor: 4.147

3.  Quality of life in patients with multiple endocrine neoplasia type 1 (MEN 1).

Authors:  G Berglund; A Lidén; M G Hansson; K Oberg; P O Sjöden; K Nordin
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

Review 4.  Scanxiety: a scoping review about scan-associated anxiety.

Authors:  Kim Tam Bui; Roger Liang; Belinda E Kiely; Chris Brown; Haryana M Dhillon; Prunella Blinman
Journal:  BMJ Open       Date:  2021-05-26       Impact factor: 2.692

5.  Patient's needs and preferences in routine follow-up after treatment for breast cancer.

Authors:  G H de Bock; J Bonnema; R E Zwaan; C J H van de Velde; J Kievit; A M Stiggelbout
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640

Review 6.  Should women under 50 be screened for breast cancer?

Authors:  S Moss
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.